G Molino

Author PubWeight™ 22.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A modular approach for representing and executing clinical guidelines. Artif Intell Med 2001 2.49
2 [HEPASCORE: a decision-support system for the identification, clinical staging and functional assessment of hepatopathies]. Ann Ital Med Int 1999 1.40
3 ProbeDesigner: for the design of probesets for branched DNA (bDNA) signal amplification assays. Bioinformatics 1999 1.23
4 Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 1997 0.99
5 Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man. J Clin Invest 1983 0.92
6 Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition. J Clin Endocrinol Metab 1969 0.89
7 An expert system for the evaluation of liver functional assessment. J Med Syst 1984 0.88
8 Relationship between the intrahepatic expression of 'e' and 'c' epitopes of the nucleocapsid protein of hepatitis B virus and viraemia. Clin Exp Immunol 1989 0.86
9 Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. J Hepatol 1996 0.86
10 Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations. Dig Dis Sci 1999 0.83
11 Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism. Gastroenterology 1987 0.82
12 Evidence of an increased nitric oxide production in primary biliary cirrhosis. Am J Gastroenterol 2001 0.80
13 Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow. Dig Dis Sci 1987 0.79
14 Sorbitol removal by the metastatic liver: a predictor of systemic toxicity of intra-arterial chemotherapy in patients with liver metastases. J Hepatol 1999 0.79
15 Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a scintigraphic and pharmacokinetic approach. Cancer Chemother Pharmacol 1999 0.78
16 Short-term effects of transjugular intrahepatic portosystemic shunt (TIPS) on functional liver plasma flow in patients with advanced cirrhosis. Liver 1998 0.77
17 Simulation of the metabolism and enterohepatic circulation of endogenous chenodeoxycholic acid in man using a physiological pharmacokinetic model. Eur J Clin Invest 1986 0.77
18 Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review. Aging Clin Exp Res 2013 0.77
19 Bromsulphalein (BSP) kinetics in the rat: a new approach in evaluating experimental hepatotoxicity. Int Arch Occup Environ Health 1982 0.77
20 Effect of perioperative infusion of antioxidants on neutrophil activation during liver transplantation in humans. Transplant Proc 2002 0.77
21 [Behavior of serum alpha 1-antitrypsin in chronic hepatopathies and its diagnostic significance]. Quad Sclavo Diagn 1980 0.76
22 Structural analysis of compartmental models for the hepatic kinetics of drugs. J Lab Clin Med 1975 0.76
23 New results on saturation phenomena in BSP metabolism: the role of free and conjugated BSP. Med Biol Eng Comput 1981 0.76
24 Executing clinical guidelines: temporal issues. Proc AMIA Symp 2000 0.75
25 Evaluation of the diagnostic value of serum bile acid in the detection and functional assessment of liver diseases. Ann Clin Biochem 1985 0.75
26 Rhabdomyolysis as the epiphenomenon of unrecognised celiac sprue. Panminerva Med 2003 0.75
27 Sorbitol clearance: a parameter reflecting liver plasma flow in the rat. Res Commun Chem Pathol Pharmacol 1986 0.75
28 [The kinetics of radioactive (I 131) rose bengal in the eifferential diagnosis of normal subjects and patients with liver cirrhosis and cholestasis]. Boll Soc Ital Biol Sper 1968 0.75
29 [Diagnostic value of the trace elements and related carrier proteins in chronic liver diseases]. Minerva Dietol Gastroenterol 1983 0.75
30 [Persistance of the adrenocortical circadian rhythm in the course of submaximal corticoid inhibition obtained with a preparation with delayed absorption]. Folia Endocrinol 1968 0.75
31 [Gas-chromatographic profile of steroids in the urine in hepatic cirrhosis]. Boll Soc Ital Biol Sper 1974 0.75
32 Effects of nifedipine on functional liver plasma flow in normal subjects and in patients with cirrhosis. Clin Pharmacol Ther 1993 0.75
33 [Modifications of the gas chromatographic pattern of urinary corticosteroids induced by various doses of beta 1-24 corticotropin]. Folia Endocrinol 1973 0.75
34 [Steroid gas-chromatogram changes under the influence of ACTH]. Rev Fr Endocrinol Clin 1971 0.75
35 [Effects of blocking muscarinic receptors with pirenzepine on the functional plasma flow of the liver in man and in the rat]. Recenti Prog Med 1985 0.75
36 Non-invasive evaluation of portal-systemic shunting in man by D-sorbitol bioavailability. J Hepatol 1987 0.75
37 [Circadian changes in the urinary excretion of the principal free corticosteroids and glucuronoconjugates]. Folia Endocrinol 1973 0.75
38 [Changes in the gas-chromatographic pattern of urinary steroids induced with prolonged corticotropin stimulation]. Folia Endocrinol 1974 0.75
39 [Functional and circulatory evaluation of the liver in recent hyperthyroidism]. Fegato 1965 0.75
40 [Changes in the cortisol/cortisone ratio in humans caused by corticotropin stimulation]. Boll Soc Ital Biol Sper 1974 0.75
41 [Applicability of gas-liquid chromatography to analysis of urinary catabolites of corticosteroids]. Folia Endocrinol 1968 0.75
42 Diagnostic value of prealbumin and retinol-binding protein in acute and chronic liver diseases. Ric Clin Lab 1985 0.75
43 Objective assessment of the contribution of each diagnostic test and of the ordering sequence in jaundice caused by pancreatobiliary carcinoma. Scand J Gastroenterol 2000 0.75
44 Computer simulation of portal venous shunting and other isolated hepatobiliary defects of the enterohepatic circulation of bile acids using a physiological pharmacokinetic model. Hepatology 1988 0.75
45 Assessment of functional liver mass and plasma flow in acromegaly before and after long-term treatment with octreotide. Metabolism 1996 0.75
46 [Gas chromatographic determination of the fatty acids of serum phosphatides separated by thin layer chromatography]. Boll Soc Ital Biol Sper 1964 0.75
47 The kinetics of I-131 rose bengal in normal and cirrhotic subjects studied by compartmental analysis and a digital computer. J Lab Clin Med 1966 0.75
48 [Pathophysiological and therapeutic implications of nitric oxide in hepatology]. Minerva Gastroenterol Dietol 2002 0.75
49 Hyperhomocysteinemia in preeclampsia is associated to higher risk pressure profiles. Eur Rev Med Pharmacol Sci 2003 0.75
50 [Formation of methoxy-trimethylsilyl derivatives of corticosteroids]. Folia Endocrinol 1968 0.75
51 A sequential protocol for the optimization of diagnostic procedures in hepatology. J Med Syst 1984 0.75
52 [Hepatic clearance of sulfobromophthalein administered in small doses in subjects with hepatobiliary diseases]. Minerva Gastroenterol 1968 0.75
53 [Thin layer chromatography of bromsulphalein metabolites: determination of blood metabolites]. Minerva Gastroenterol 1966 0.75
54 An electronic medical diary for computer assisted patient management. Minerva Med 2003 0.75
55 Insulin resistance in human liver cirrhosis is not modified by porto-systemic surgical shunt. Acta Endocrinol (Copenh) 1986 0.75
56 [Thermostabilization of corticosteroid molecules for gas chromatography]. Steroidologia 1970 0.75
57 D-sorbitol plasma disappearance rate: an index to evaluate changes in liver circulation. Ric Clin Lab 1989 0.75
58 Qualitative and quantitative evaluation of liver diseases: functional classifications. J Biomed Eng 1983 0.75
59 Blood kinetics of a low dose of iodoxamate. Rays 1987 0.75
60 Prediction by mathematical simulation of different pathophysiological effects on D-sorbitol bioavailability. Comput Biol Med 1998 0.75
61 [Experimental observations on the applicability of gas-liquid chromatography to analysis of steroids of the cortisol and corticosterone series]. Boll Soc Ital Biol Sper 1968 0.75
62 Computerized approach to active and objective quality control of patient care. Int J Biomed Comput 1996 0.75
63 Pirenzepine does not impair liver blood flow in the rat. Int J Tissue React 1983 0.75
64 Circadian variation of 21- and 11 -hydroxylase activity in the biosynthesis of cortisol. J Endocrinol 1971 0.75
65 Emerging risk factors and assessment of organ damage in postmenopausal hypertensive women. Panminerva Med 2003 0.75
66 [Changes in plasma lipids and lipoproteins in chronic liver diseases]. Quad Sclavo Diagn 1981 0.75
67 LIED--liver: information, education and diagnosis. Methods Inf Med 1992 0.75
68 Contextual and temporal clinical guidelines. Proc AMIA Symp 1998 0.75
69 [Methods of use of bis-trimethyl-silyl-acetamide (BSA) in the formation of thermostable derivatives of corticosteroids]. Boll Soc Ital Biol Sper 1968 0.75
70 Effect of adrenocorticotrophin on 21- and 11 -hydroxylase activity in the biosynthesis of cortisol. J Endocrinol 1973 0.75
71 Clinical database. Structure, development strategies and expected clinical applications. Minerva Med 2003 0.75
72 Scoring procedures in clinical hepatology. Forum (Genova) 1999 0.75
73 Hyperhomocysteinemia in menopausal hypertension: an added risk factor and a dangerous association for organ damage. Eur Rev Med Pharmacol Sci 2003 0.75
74 Discrimination of hepatobiliary diseases by the evaluation of bromsulfophthalein blood kinetics. J Lab Clin Med 1978 0.75
75 Should blood transport kinetics be modeled in metabolic processes? Am J Physiol 1984 0.75
76 [Analysis of the BSF plasma clearance curve, using compartmental models]. Boll Soc Ital Biol Sper 1974 0.75
77 PEPTY: a knowledge-based program for assisting medical reasoning in peptic diseases. Comput Methods Programs Biomed 1989 0.75
78 [Antipyrine clearance in liver resections]. Minerva Dietol Gastroenterol 1991 0.75
79 [Thin layer chromatography of bromsulphalein metabolites: determination of biliary metabolites]. Minerva Gastroenterol 1966 0.75
80 [Methods of preparation of thermostable derivatives of corticosteroids: formation of trimethyl-silyl-esters of methoxime]. Boll Soc Ital Biol Sper 1968 0.75